The Patent Finder

Janssen Biologics B.V.

Also on record
Records under this name other than patents Janssen Biologics B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Janssen Biologics B.V.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,775,014Multiparameter Materials, Methods and Systems for Enhanced Bioreactor Manufacture
In force
 · Medium confidence
In forceMedium confidence
US 12,534,524Manufacturing Methods for Producing Anti-TNF Antibody Compositions
In force
 · High confidence
In forceHigh confidence
US 11,149,085Manufacturing Methods to Control C-Terminal Lysine, Galactose and Sialic Acid Content in Recombinant Proteins
Lapsed on the fee record
Ended Oct 19, 2025 · High confidence
Lapsed on the fee recordEnded Oct 19, 2025High confidence
14/207,915Manufacturing Methods to Control C-Terminal Lysine, Galactose and Sialic Acid Content in Recombinant Proteins
Abandoned
Abandoned Jan 11, 2016
AbandonedAbandoned Jan 11, 2016
17/489,744Manufacturing Methods To Control C-Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins
Abandoned
Abandoned Feb 24, 2024
AbandonedAbandoned Feb 24, 2024
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited